Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731860 · ClinicalTrials.gov registry record · NA
Pilot Study Intended to Provide Input for Future Designs Using the PET Alpha Ring Detector
A NA study of Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology., sponsored by Philips Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT01731860: Completed NA study of Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology., sponsored by Philips Healthcare.
NCT01731860 is a NA study of Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology. that has completed, run by Philips Healthcare. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01731860, a NA study of Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology., has completed, sponsored by Philips Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
A standard PET/CT scanner is comprised of two different machines: An X-ray computed tomography scanner (CT), which gives information about your anatomy, and a Positron Emission Tomography scanner (PET) that provides information about how the body functions. Both of these work together to make the final images for doctors to review. As part of this research study the investigators would like to test a new scanner technology by evaluating the quality of the images obtained using this new PET system. The scanner the investigators would use is able to do both types of examination, the standard PET/CT and the additional research PET. The new PET system adds a second scanner ring to the standard PET/CT. This allows the patient to stay on the same imaging table for both studies. Being in this study does not change how the standard PET/CT will be done.
Primary Outcome
Images acquired using the investigational device will be compared with the images obtained using the approved clinical device. The qualitative image review will be performed by the reading radiologist/nuclear medicine physician.
Conditions Studied
Interventions
- DEVICE Additional PET Scan
Study Locations (1)
Ohio
- University Hospital Case Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-11 |
| Phase | NA |
What the finished NCT01731860 record still lists
NCT01731860 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology. appearing as the primary indexed condition, and to 1 intervention - of which Additional PET Scan is the first listed.
NCT01731860 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01731860 about?
NCT01731860 is a clinical study titled "Pilot Study Intended to Provide Input for Future Designs Using the PET Alpha Ring Detector". A standard PET/CT scanner is comprised of two different machines: An X-ray computed tomography scanner (CT), which gives information about your anatomy, and a Positron Emission Tomography scanner (PET) that provides information about how the body functions. Both of these work together to make the fi...
What is the current status of trial NCT01731860?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2012-11.
What conditions does trial NCT01731860 study?
This clinical trial studies the following conditions: Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology..
What interventions are being tested in trial NCT01731860?
The interventions under investigation include: Additional PET Scan (DEVICE).
Who is sponsoring clinical trial NCT01731860?
This trial is sponsored by Philips Healthcare, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01731860 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01731860's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia